Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.47-$8.59 to $8.50-$8.60 vs $8.54 Est; Narrows FY2026 Sales Guidance from $8.553B-$8.635B to $8.594B-$8.635B vs $8.597B Est
Benzinga Newsdesk 7 hours ago
NewsGuidance
Zimmer Biomet Holdings (NYSE:ZBH) raises FY2026 Adj EPS guidance from $8.47-$8.59 to $8.50-$8.60 vs $8.54 analyst estimate. Narrows FY2026 sales outlook from $8.553 billion-$8.635 billion to $8.594 billion-$8.635
Zimmer Biomet Holdings (NYSE:ZBH) raises FY2026 Adj EPS guidance from $8.47-$8.59 to $8.50-$8.60 vs $8.54 analyst estimate. Narrows FY2026 sales outlook from $8.553 billion-$8.635 billion to $8.594 billion-$8.635 billion vs $8.597 billion estimate.